SunPower (NASDAQ:SPWR) has once again raised the bar by introducing the highest-power solar panels available today for the residential market. In the United States, the company has launched its Next Generation Technology home solar panel called A-Series, delivering 400 and 415 watts of power. In Europe and Australia, homeowners can also now order a 400-watt solar panel from SunPower called Maxeon® 3. Each is the first home solar panel to deliver more than 400 watts in its region and is designed to deliver 60 percent more energy in the same amount of roof space over the first 25 years compared to conventional solar.
“SunPower is introducing the world’s first 400-watt residential solar panels as most in the industry are just crossing the 300-watt threshold for home solar,” said Jeff Waters, CEO of the SunPower Technologies business unit. “Our record-breaking cell technology and innovative research and development efforts have enabled us to fit more power capacity on rooftops than we ever have before. Our growing panel portfolio is delivering unprecedented value across global markets that goes unmatched by any other residential solar technology currently available.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8252054-sunpower-a-series-next-gen-solar-panels/
Dozens of actors, musicians, sports personalities and other distinguished guests donated their time on September 11th to honor the memories of those who lost their lives on 9/11 by raising more than $12 million for charities around the world. This special event, called Charity Day, is hosted each year by BGC Partners, Inc. (NASDAQ: BGCP) (“BGC Partners” or “BGC”), a leading global brokerage company servicing the financial and real estate markets, and its affiliates Cantor Fitzgerald and GFI Group. Celebrities who attended the event included Matthew McConaughey, Common, and Liev Schreiber in New York, and Nicole Scherzinger, Tom Hardy and Jimmy Carr in London.
In addition to the millions of dollars raised for many worthy causes, BGC Partners, Cantor Fitzgerald and GFI Group announced they are raising $5 million for the families severely impacted by Hurricanes Maria and Jose in Puerto Rico. These funds will be raised over the next several months and prepaid $1000 American Express® cash cards will be distributed to 5,000 families in January 2019.
To view the multimedia release go to:
https://www.multivu.com/players/English/8320352-bgc-partners-2018-charity-day/
Equinix, Inc. (Nasdaq: EQIX), the global interconnection and data center company, today announced that its Board of Directors has appointed Charles Meyers to the position of President and Chief Executive Officer, effective immediately. Meyers will also join Equinix’s Board of Directors. He succeeds Peter Van Camp, who has served as interim CEO since January 2018. Van Camp will resume his role as Executive Chairman of the Equinix Board of Directors.
To view the multimedia release go to:
https://www.multivu.com/players/English/8059152-equinix-charles-meyers-president-ceo/
TeleTech Holdings, Inc. (NASDAQ: TTEC) a global customer experience company that designs, builds and operates captivating omnichannel customer experiences on behalf of the world’s most prestigious and innovative brands announced today that it has changed its name to TTEC (pronounced T-tec). With this new name, the company is affirming that it has successfully evolved to become an end-to-end strategic business partner in the design and delivery of world-class customer experience, engagement, growth, and digital trust and safety services.
To view the multimedia release go to:
https://www.multivu.com/players/English/8226851-cx-innovator-teletech-announces-name-change-to-ttec/
Axon (Nasdaq: AAXN), the global leader in connected law enforcement technology, today announced the results of a study that sheds new light on the growing difficulties law enforcement agencies face in their recruitment efforts. In response to the study, conducted in conjunction with Wakefield Research, Axon is launching the “I'm In” Recruiting Campaign to help raise awareness and provide agencies with new tools to recruit the next generation of police. To learn more please visit www.connectandserve.in.
The Wakefield Research study surveyed 200 law enforcement officers across the U.S. who revealed they've experienced a sharp downturn of new applications to their agencies. More than half (54 percent) of the respondents said the number of job applications to their department has decreased in the last five years. Meanwhile, 83 percent of officers think that it will be even more difficult to recruit new candidates in the next five years.
To view the multimedia release go to:
https://www.multivu.com/players/English/8012852-axon-im-in-recruiting-support-campaign/
Four-time PGA TOUR winner Tim Herron is teaming up with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), Damon Adamany, MD, of The CORE Institute and the Facts on Hand campaign to educate adults about one of the more common hand conditions. The campaign is raising awareness of Dupuytren’s Contracture, a progressive, potentially disfiguring hand condition affecting a layer of tissue underneath the palms that can cause one or more fingers to move into a bent position so they cannot be straightened.
Dupuytren’s Contracture, sometimes referred to as “Viking Disease,” can make everyday tasks difficult, such as grabbing an object at home, or in Tim Herron’s case, a nine iron from his golf bag. Many people live with the disease without being diagnosed because they mistakenly assume they have arthritis or another hand condition. And because Dupuytren’s Contracture may progress slowly, people may not pay attention to it until they can no longer straighten their fingers, complicating everyday activities.
To view the multimedia release go to:
https://www.multivu.com/players/English/8153851-endo-facts-on-hand-dupuytrens-contracture/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
TASER International (Nasdaq: TASR), the global leader in connected law enforcement technologies, announced today that it is launching a new program to equip every police officer in America with a body camera and changing its name to Axon (Nasdaq: AAXN). It will also provide supporting hardware, software, data storage, training, and support to police departments free of cost for one year.
“We are going 'all-in' to empower police officers to more safely and effectively do their jobs and drive important social change by making body cameras available to every officer in America,” said Rick Smith, Founder and CEO of Axon. “We believe these cameras are more than just tools to protect communities and the officers who serve them. They also hold the potential to change police work as we know it, by seamlessly collecting an impartial record and reducing the need for endless paperwork. That's why we're giving this opportunity to every single police officer in America.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8012851-taser-rebrand-axon-free-body-cameras/
In California where over one-third of the country’s vegetables and two-thirds of the country’s fruits and nuts are grown, businesses in the agricultural industry are looking for ways to reduce costs while continuing to deliver high quality products. In one of the nation’s sunniest states, farmers, food processers, beverage suppliers and more have used complete solar solutions from SunPower (NASDAQ:SPWR) to save on one of their largest operating expenses: electricity.
One grower-owned almond processor based in the 7-square-mile town of Buttonwillow, Calif., now offsets 90 percent of its electricity costs with a 1-megawatt SunPower® Helix™ system. Golden Empire Shelling can see up to 70 million pounds of almonds roll through its state-of-the-art facility each year. With limited land and water resources in the area, the company chose a solar solution that delivers 29 percent more energy per square foot compared to conventional systems, and can be robotically cleaned with 75 percent less water than manual methods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7706154-sunpower-solar-solutions-for-agricultural-industry/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced the winners of its 2016 Health Hero Awards (http://www.webmd.com/healthheroes/what-is-hero), recognizing individuals who are changing the healthcare landscape by meeting a health challenge and giving back to others. This year’s winners are Seth Rogen and Lauren Miller Rogen, Ed Damiano, PhD, Betty Ferrell, RN, PhD and Trisha Prabhu.
On November 3, 2016, an accomplished and inspiring lineup of presenters and performers will gather to honor the winners at the 3rd Annual WebMD Health Hero Awards gala, hosted by Good Morning America co-anchor Robin Roberts. This year’s presenters include David Krumholtz, Adam Savage, and Sarah Wynter, with musical performances by A Great Big World and Naturally 7.
To watch the red carpet arrivals as they happen live from the TimesCenter in New York City, follow WebMD on www.facebook.com/webmd beginning at 6:30 PM ET on November 3, and be sure to follow @WebMD on Instagram, Snapchat and Twitter for updates throughout the night with #HealthHeroes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579756-webmd-2016-health-hero-awards/
CoStar Group, Inc. (NASDAQ: CSGP) has selected Richmond, Virginia for its research operations headquarters, following a national search. As a result, CoStar expects to create approximately 730 jobs in Richmond and invest a quarter billion dollars into the local economy.
CoStar Group creates and delivers the information, marketing, and analytic tools that facilitate the vast majority of commercial real estate transactions in the United States. The CoStar research team curates and certifies information on approximately $1 trillion of potential real estate transactions and tracks billions of dollars of completed deals.
To view the multimedia release go to:
http://www.multivu.com/players/English/7963151-costar-group-selects-richmond-for-research-operations-headquarters/
